Frankel W, Chan A, Corringham R E, Shepherd S, Rearden A, Wang-Rodriguez J
UCSD Medical Center, La Jolla, USA.
Am J Hematol. 1996 Aug;52(4):281-7. doi: 10.1002/(SICI)1096-8652(199608)52:4<281::AID-AJH7>3.0.CO;2-O.
Chimerism can be monitored after HLA-matched allogeneic bone marrow transplantation (BMT) or allogeneic peripheral blood stem cell transplantation (PBSCT) by detecting polymorphisms in short tandem repeats (STR). The purpose of our study was to document early complete chimerism in BMT and PBSCT recipients using STR, and to determine whether the initial WBC recovery correlated with the days required to attain complete chimerism. A total of 5 patients (2 PBSCT and 3 BMT) were followed by STR after transplantation. Peripheral blood obtained prior to transplantation was used to determine the 2 most informative STR probes for each donor/recipient pair. STR were amplified by polymerase chain reaction (PCR) with 8 commercial probes, and PCR products were visualized with silver staining. Peripheral blood was evaluated daily post-transplantation for WBC counts and to identify the presence of mixed or full chimerism by STR. The sensitivity of the STR technique varied from 0.05 to 1%, depending on the probe. Full chimerism was documented between day 9 and 14 in PBSCT recipients and on day 14 and 16 in BMT recipients. The initial rise in WBC occurred within 3 days of the onset of full chimerism, indicating that full chimerism is a more sensitive indicator of early engraftment. Periodic recipient monitoring using STR after complete chimerism identifies those patients who revert to mixed chimeras. The STR method may be useful in future studies to determine the significance of early engraftment and the clinical implications of sustained complete chimerism or mixed chimerism.
通过检测短串联重复序列(STR)中的多态性,可在人类白细胞抗原(HLA)匹配的异基因骨髓移植(BMT)或异基因外周血干细胞移植(PBSCT)后监测嵌合现象。我们研究的目的是利用STR记录BMT和PBSCT受者早期完全嵌合情况,并确定初始白细胞恢复是否与达到完全嵌合所需天数相关。共有5例患者(2例PBSCT和3例BMT)在移植后接受STR随访。移植前采集的外周血用于确定每个供者/受者对的2个信息量最大的STR探针。使用8种商业探针通过聚合酶链反应(PCR)扩增STR,PCR产物用银染法可视化。移植后每天评估外周血白细胞计数,并通过STR鉴定混合嵌合或完全嵌合的存在。根据探针不同,STR技术的灵敏度在0.05%至1%之间。PBSCT受者在第9至14天记录到完全嵌合,BMT受者在第14至16天记录到完全嵌合。白细胞的初始升高发生在完全嵌合开始后的3天内,表明完全嵌合是早期植入的更敏感指标。在完全嵌合后使用STR对受者进行定期监测,可识别那些恢复为混合嵌合体的患者。STR方法可能在未来研究中用于确定早期植入的意义以及持续完全嵌合或混合嵌合的临床意义。